Showing 1 posts of 1 posts found.
AstraZeneca is to pay $50 million up front to get a worldwide licensing deal for one of Merck’s investigational drugs …
Weber is new CMO at Sensorion
Charity commits £800,000 to AI research into late breast cancer recurrence
AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over
Acumetis CEO Herspiegel steps down as Burden assumes role
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia